Multi-client queue
One co-pilot across the book, not one-hospital theatre. Billers work denials from many providers in a single queue.
AppealIQ
AppealIQ drafts denial-appeal letters for outsourced US RCM teams on multi-client queues. Human review is the default before anything goes out.
Dear Medical Review,
We respectfully request reconsideration of the denial dated above. Documentation supports medical necessity for the procedure as ordered…
AppealIQ writes the letter from imported docs and biller notes.
Human review is the default before anything leaves the queue.
Export PDF/DOCX. Send stays outside the product.
What ops already watches
Mid-value denials age while skilled appeal time stays flat.
Triage is not enough when every appeal still starts as a letter that hasn’t been written.
One biller book, many providers — drafting stalls hit every client queue.
Industry context only, not AppealIQ results: Kodiak, $48.4B US hospital denial leakage in 2025 (+25% YoY). We do not publish recovered dollars.
What you get
One co-pilot across the book, not one-hospital theatre. Billers work denials from many providers in a single queue.
Generate is disabled when rules say don’t — duplicate, max benefits, other. Rules recoverability is source of truth; AI does not override.
Open denials, dollars at risk, drafted/exported, overdue. Dollars at risk means denied dollars still open — not money recovered.
Waystar-class suites already ship GenAI appeal drafting. Keep the suite when you need platform breadth; add AppealIQ when multi-client RCM time-to-value matters.
The loop
What ships today stays human-in-the-loop. Full walkthrough on How it works.
Rules decide recoverability. Unwinnable stays out of Generate.
Advisory second opinion. Does not override rules.
Letter from imported clinical docs plus biller notes.
Review + PDF/DOCX. Send stays outside the product.
Autopilot / auto-submit is on the roadmap — not shipped. Never “Submitted to payer” as our product.
Leave with yes or no on a paid US RCM pilot conversation. Synthetic demo. Do not send production PHI.